Atlas Trials

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Clinical trial NCT02393183 · WITHDRAWN

Trial details

NCT number
NCT02393183
Sponsor
Iran University of Medical Sciences
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease
Start date
2019-07-15
Primary completion
2022-06-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.